Sallee FR - Search Results

1

The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

Hodgkins P, Shaw M, McCarthy S, Sallee FR. Hodgkins P, et al. Among authors: sallee fr. CNS Drugs. 2012 Mar 1;26(3):245-68. doi: 10.2165/11599630-000000000-00000. CNS Drugs. 2012. PMID: 22329564 Review.

2

Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to management.

Childress AC, Sallee FR. Childress AC, et al. Among authors: sallee fr. CNS Drugs. 2014 Feb;28(2):121-9. doi: 10.1007/s40263-013-0130-6. CNS Drugs. 2014. PMID: 24402970 Review.

3

Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy.

Childress AC, Sallee FR. Childress AC, et al. Among authors: sallee fr. CNS Drugs. 2015 Aug;29(8):683-93. doi: 10.1007/s40263-015-0264-9. CNS Drugs. 2015. PMID: 26267739 Review.

4

Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

Connor DF, Findling RL, Kollins SH, Sallee F, López FA, Lyne A, Tremblay G. Connor DF, et al. CNS Drugs. 2010 Sep;24(9):755-68. doi: 10.2165/11537790-000000000-00000. CNS Drugs. 2010. PMID: 20806988 Clinical Trial.

5

An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations.

Childress AC, Komolova M, Sallee FR. Childress AC, et al. Among authors: sallee fr. Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):937-974. doi: 10.1080/17425255.2019.1675636. Epub 2019 Nov 8. Expert Opin Drug Metab Toxicol. 2019. PMID: 31581854 Free article. Review.

6

A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.

Ambrosini PJ, Sallee FR, Lopez FA, Shi L, Michaels MA; LADD.CAT Study Group. Ambrosini PJ, et al. Among authors: sallee fr. Curr Med Res Opin. 2006 Feb;22(2):427-40. doi: 10.1185/030079906X80639. Curr Med Res Opin. 2006. PMID: 16466615

7

Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.

Childress AC, Sallee FR. Childress AC, et al. Among authors: sallee fr. Drugs Today (Barc). 2012 Mar;48(3):207-17. doi: 10.1358/dot.2012.48.3.1750904. Drugs Today (Barc). 2012. PMID: 22462040 Review.

8

Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD.

Childress AC, Cutler AJ, Po MD, DeSousa NJ, Warrington LE, Sallee FR, Incledon B. Childress AC, et al. Among authors: sallee fr. J Clin Psychiatry. 2021 Jun 22;82(4):21m13914. doi: 10.4088/JCP.21m13914. J Clin Psychiatry. 2021. PMID: 34166587 Free article. Clinical Trial.

9

The use of lisdexamfetamine dimesylate for the treatment of ADHD.

Childress AC, Sallee FR. Childress AC, et al. Among authors: sallee fr. Expert Rev Neurother. 2012 Jan;12(1):13-26. doi: 10.1586/ern.11.175. Expert Rev Neurother. 2012. PMID: 22243042 Review.

10

Early Morning Functional Impairments in Stimulant-Treated Children with Attention-Deficit/Hyperactivity Disorder Versus Controls: Impact on the Family.

Faraone SV, Schachar RJ, Barkley RA, Nullmeier R, Sallee FR. Faraone SV, et al. Among authors: sallee fr. J Child Adolesc Psychopharmacol. 2017 Oct;27(8):715-722. doi: 10.1089/cap.2016.0164. Epub 2017 Apr 10. J Child Adolesc Psychopharmacol. 2017. PMID: 28394175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters